Acquisition - June 2, 2022
Senzime to acquire Respiratory Motion
Senzime has signed an agreement to acquire 100 percent of the shares in the US company Respiratory Motion, Inc. for an initial consideration of 19 million USD on a cash- and debt-free basis with an additional potential earn-out payment of up to 25 million USD, paid out earliest in 2024. The sellers consist of a […]
Business article - July 4, 2021
Interview: Pia Renaudin, CEO, Senzime
Last week Senzime’s shares were admitted for trading on Nasdaq Stockholm’s main market and NLS asked its CEO about leadership, being a female CEO and about Senzime’s achievements so far. Senzime develops and markets CE- and FDA cleared patient monitoring systems driven by algorithms and sensors to closely monitor patients under anesthesia. The company’s system […]
Financing - December 4, 2020
Senzime raises proceeds of approximately SEK 100 million
Senzime has successfully completed a directed issue of 4,545,000 shares, at a subscription price of SEK 22 per share, raising proceeds of approximately SEK 100 million. A number of Swedish and international institutional investors, including The Fourth Swedish National Pension Fund, Swedbank Robur Microcap, TIN Fonder, Handelsbanken Fonder, FE Småbolag Sverige and ÖstVäst Capital Management, […]
Agreement - February 16, 2017
Senzime signs distribution agreement
Senzime has entered distribution agreements for the commercialization of TetraGraph with Wardray Premise, who will be the exclusive distributor in the UK and Ireland and LSR Healthcare who will be the exclusive distributor in Australia and New Zealand. Compensation to distributors will be paid on a “per-unit sold” basis, and is in line with current […]
Acquisition - May 4, 2016
Senzime acquires Acacia Designs
Swedish Senzime has entered into an agreement to acquire Acacia Designs BV, an international development company within anesthesia monitoring. The acquisition will be financed by 16,076,730 newly issued shares in Senzime through a non-cash issue. After the acquisition, Acacia’s shareholders will own 50 percent of the shares in Senzime. In connection with the acquisition, a […]
Acquisition - April 24, 2015
MD Biomedical Joins Senzime
Umeå spin-off and medtech company MD Biomedical has been acquired by Swedish company Senzime as a subsidiary, according to Biotech Umeå. MD Biomedical has developed a probe called Onzurf, which can be used to monitor the status of an organ from the surface. The development was based on MD Biomedical’s research at Umeå University and […]